There are a lot of scary threats in the world – extreme weather, terrorist attacks, deadly infectious diseases, mass shootings – but if healthcare organisations plan ahead for such disasters, lives can be saved.
Continue reading…
What happens when disaster strikes
Posted on Leave a comment
A first for South Africa:- Biosimilar oncology drug authorised for use
Posted on Leave a comment
Cipla, South Africa’s third-largest pharmaceutical manufacturer, in collaboration with Teva Pharmaceutical Industries Ltd, has announced the launch of the country’s first biosimilar for the oncology and haematology markets.
Continue reading…
Hot Medical News:- Hi-tech lung cancer lab to benefit all
Posted on Leave a comment
If the country is to reduce its high cancer statistics, the public would have to be educated about the illness and preventative measures taken, says Gauteng Health MEC, Dr Gwen Ramokgopa.
Continue reading…
Do you really think you’re going to opt out of the NHI when it comes?
Posted on Leave a comment
If the National Health Insurance (NHI) Bill is passed in its current form, the NHI will be compulsory, regardless of whether you also belong to a private medical aid. So, opting out won’t be possible.
Continue reading…
3D printing disruption, medical implant sector ripe
Posted on Leave a comment
Medical technology which is often expensive at the time of market entry becomes cheaper over time. But 3D printing in medicine has started to revolutionise the field, especially with its rapidly declining costs and increased accessibility of the technology.
Continue reading…
The big question:- Why South Africa needs to discipline the private healthcare industry
Posted on Leave a comment
If a service is provided by a company rather than government, this does not automatically mean a market is at work. The point is fairly obvious but has passed many in South Africa by.
Private provision of services is moving into the spotlight in South Africa as the government looks to make the health system more accessible to the poor. One aspect is the Health Market Inquiry,
Continue reading…
Pharma’s role in the government’s National Health Insurance
Posted on Leave a comment
In its current form, the proposed National Health Insurance (NHI) is by no means perfect and there remains a lot of uncertainty around funding, medical skills shortages, the role medical aids will play and how infrastructural problems, wastage and corruption in the public sector will be tackled.
Continue reading…
Will the HMI insights get lost in the rush to finalise healthcare laws?
Posted on Leave a comment
Has the almost simultaneous release of the National Health Insurance (NHI) Bill, the Medical Schemes Amendment Bill and the provisional findings of the Health Market Inquiry (HMI) created an information overload, where some of the insights from the inquiry could be lost in the noise?
Continue reading…
New Survey: Medical aid members have more choice
Posted on Leave a comment
In the battle for a slice of the private healthcare market, there has been significant growth in the number of medical schemes performing well across all sections of the medical aid spectrum. Whilst this means that members get more choice, it also makes the landscape increasingly complex.
Continue reading…
A new Prostate treatment byproduct could accelerate cancer cell growth
Posted on Leave a comment
New research out of the United States points to a genetic anomaly in certain men with prostate cancer, which may impact their response to common drugs used to treat the disease.
Researchers found that abiraterone, a common prostate cancer drug, yields high levels of a testosterone-like byproduct in men with advanced disease who have a specific genetic variant.
Continue reading…